Moleculin Biotech
Stock Forecast, Prediction & Price Target
Moleculin Biotech Financial Estimates
Moleculin Biotech Revenue Estimates
Moleculin Biotech EBITDA Estimates
Moleculin Biotech Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $34.43M Low: $34.43M High: $34.43M avg. 0% | Avg: $71.41M Low: $71.41M High: $71.41M avg. 107.40% | Avg: $41.05M Low: $41.05M High: $41.05M avg. -42.51% | Avg: $85.27M Low: $85.27M High: $85.27M avg. 107.70% |
Net Income
% change YoY
| $-8.86M N/A | $-27.41M -209.36% | $-29.76M -8.60% | Avg: $-31.37M Low: $-18.66M High: $-10.43M avg. -5.38% | Avg: $-34.53M Low: $-18.37M High: $-7.72M avg. -10.07% | Avg: $3.23M Low: $3.23M High: $3.23M avg. 109.35% | Avg: $13.97M Low: $13.97M High: $13.97M avg. 332.72% |
EBITDA
% change YoY
| $-29.53M N/A | $-31.97M -8.27% | $-29.50M 7.72% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$4.94 N/A | -$14.37 -190.89% | -$15.07 -4.87% | Avg: -$6.88 Low: -$9.45 High: -$5.28 avg. 54.32% | Avg: -$6.02 Low: -$9.3 High: -$3.91 avg. 12.54% | Avg: $1.64 Low: $1.64 High: $1.64 avg. 127.15% | Avg: $7.08 Low: $7.08 High: $7.08 avg. 332.72% |
Operating Expenses
% change YoY
| $22.96M N/A | $30.64M 33.40% | $29.63M -3.29% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Moleculin Biotech stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 106.65% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -18.66M, average is -31.37M and high is -10.43M.
What is Moleculin Biotech stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 43.14% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $34.43M, average is $34.43M and high is $34.43M.
What is Moleculin Biotech stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 131.68% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$9.45, average is -$6.88 and high is $-5.28.